D.A. Davidson & Co. Cerus Corp Transaction History

D.A. Davidson & Co.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$4.51 - $6.6 $82,672 - $120,984	-18,331 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$5.16 - $6.85 $54,443 - $72,274	-10,551 Reduced 36.53%	18,331 $114,000
Q4 2018 Jan 29, 2019	SELL	$4.89 - $7.16 $158,983 - $232,785	-32,512 Reduced 52.96%	28,882 $146,000
Q3 2018 Nov 13, 2018	SELL	$6.89 - $7.78 $332,029 - $374,918	-48,190 Reduced 43.98%	61,394 $443,000
Q2 2018 Aug 02, 2018	SELL	$5.19 - $7.25 $10,333 - $14,434	-1,991 Reduced 1.78%	109,584 $731,000
Q1 2018 May 04, 2018	SELL	$3.56 - $5.74 $14,304 - $23,063	-4,018 Reduced 3.48%	111,575 $611,000
Q4 2017 Feb 08, 2018	BUY	$2.76 - $3.95 $7,620 - $10,905	2,761 Added 2.45%	115,593 $391,000
Q3 2017 Nov 08, 2017	BUY	$2.22 - $2.73 $14,802 - $18,203	6,668 Added 6.28%	112,832 $308,000
Q2 2017 Aug 11, 2017	BUY	N/A	106,164	106,164 $0

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $331M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.